Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

417 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Etanercept therapy in children with treatment-resistant uveitis.
Reiff A, Takei S, Sadeghi S, Stout A, Shaham B, Bernstein B, Gallagher K, Stout T. Reiff A, et al. Among authors: takei s. Arthritis Rheum. 2001 Jun;44(6):1411-5. doi: 10.1002/1529-0131(200106)44:6<1411::AID-ART235>3.0.CO;2-O. Arthritis Rheum. 2001. PMID: 11407702 Free article. Clinical Trial.
Assessment of damage in juvenile-onset systemic lupus erythematosus: a multicenter cohort study.
Ravelli A, Duarte-Salazar C, Buratti S, Reiff A, Bernstein B, Maldonado-Velazquez MR, Beristain-Manterola R, Maeno N, Takei S, Gerloni V, Spencer CH, Pratsidou-Gertsi P, Ruperto N, Pistorio A, Martini A. Ravelli A, et al. Among authors: takei s. Arthritis Rheum. 2003 Aug 15;49(4):501-7. doi: 10.1002/art.11205. Arthritis Rheum. 2003. PMID: 12910556 Free article.
Health-related quality of life in juvenile-onset systemic lupus erythematosus and its relationship to disease activity and damage.
Ruperto N, Buratti S, Duarte-Salazar C, Pistorio A, Reiff A, Bernstein B, Maldonado-Velázquez MR, Beristain-Manterola R, Maeno N, Takei S, Falcini F, Lepore L, Spencer CH, Pratsidou-Gertsi P, Martini A, Ravelli A. Ruperto N, et al. Among authors: takei s. Arthritis Rheum. 2004 Jun 15;51(3):458-64. doi: 10.1002/art.20412. Arthritis Rheum. 2004. PMID: 15188334 Free article.
Etanercept in the treatment of disease-modifying anti-rheumatic drug (DMARD)-refractory polyarticular course juvenile idiopathic arthritis: experience from Japanese clinical trials.
Mori M, Takei S, Imagawa T, Imanaka H, Nerome Y, Kurosawa R, Kawano Y, Yokota S, Sugiyama N, Yuasa H, Fletcher T, Wajdula JS. Mori M, et al. Among authors: takei s. Mod Rheumatol. 2011 Dec;21(6):572-8. doi: 10.1007/s10165-011-0450-7. Epub 2011 Apr 11. Mod Rheumatol. 2011. PMID: 21479889
Intravenous abatacept in Japanese patients with polyarticular-course juvenile idiopathic arthritis: results from a phase III open-label study.
Hara R, Umebayashi H, Takei S, Okamoto N, Iwata N, Yamasaki Y, Nakagishi Y, Kizawa T, Kobayashi I, Imagawa T, Kinjo N, Amano N, Takahashi Y, Mori M, Itoh Y, Yokota S. Hara R, et al. Among authors: takei s. Pediatr Rheumatol Online J. 2019 Apr 30;17(1):17. doi: 10.1186/s12969-019-0319-4. Pediatr Rheumatol Online J. 2019. PMID: 31039807 Free PMC article. Clinical Trial.
Efficacy and safety of canakinumab in systemic juvenile idiopathic arthritis: 48-week results from an open-label phase III study in Japanese patients.
Nishimura K, Hara R, Umebayashi H, Takei S, Iwata N, Imagawa T, Shimizu M, Tomiita M, Seko N, Kitawaki T, Yokota S. Nishimura K, et al. Among authors: takei s. Mod Rheumatol. 2021 Jan;31(1):226-234. doi: 10.1080/14397595.2020.1783163. Epub 2020 Jul 29. Mod Rheumatol. 2021. PMID: 32552266 Free article. Clinical Trial.
417 results